Apolipoprotein E-deficient mice develop an anti-Chlamydophila pneumoniae T helper 2 response and resist vascular infection.
暂无分享,去创建一个
N. Therville | M. Thomsen | H. Benoist | T. Levade | B. Ségui | H. Yacoub-Youssef | Virginie Garcia | D. Nazzal
[1] T. Tsubata,et al. The Development and Function of Regulatory B Cells Expressing IL-10 (B10 Cells) Requires Antigen Receptor Diversity and TLR Signals1 , 2009, The Journal of Immunology.
[2] T. Tedder,et al. Regulatory B cells as inhibitors of immune responses and inflammation , 2008, Immunological reviews.
[3] C. Leclerc,et al. Regulatory B and T cells in infections. , 2008, Microbes and infection.
[4] G. Martens,et al. Hypercholesterolemia Impairs Immunity to Tuberculosis , 2008, Infection and Immunity.
[5] S. Pillai,et al. Peripheral B cell subsets. , 2008, Current opinion in immunology.
[6] C. Leclerc,et al. Type I interferons protect neonates from acute inflammation through interleukin 10–producing B cells , 2007, The Journal of experimental medicine.
[7] D. Rader,et al. Apolipoprotein E Suppresses the Type I Inflammatory Response In Vivo , 2005, Circulation research.
[8] L. Bockenstedt,et al. Infection-Induced Marginal Zone B Cell Production of Borrelia hermsii-Specific Antibody Is Impaired in the Absence of CD1d 1 , 2005, The Journal of Immunology.
[9] D. Grainger,et al. Apolipoprotein E Modulates Clearance of Apoptotic Bodies In Vitro and In Vivo, Resulting in a Systemic Proinflammatory State in Apolipoprotein E-Deficient Mice1 , 2004, The Journal of Immunology.
[10] D. Ojcius,et al. Chlamydia and apoptosis: life and death decisions of an intracellular pathogen , 2004, Nature Reviews Microbiology.
[11] M. Netea,et al. Apolipoprotein-E-deficient mice exhibit an increased susceptibility to disseminated candidiasis. , 2004, Medical mycology.
[12] L. Jacobs,et al. Chlamydia pneumoniae stimulates IFN-gamma synthesis through MyD88-dependent, TLR2- and TLR4-independent induction of IL-18 release. , 2004, Journal of immunology.
[13] Eran Leitersdorf,et al. Atherosclerosis in the apolipoprotein-E-deficient mouse: a decade of progress. , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[14] B. Strandvik,et al. Severe Hypercholesterolaemia Leads to Strong Th2 Responses to an Exogenous Antigen , 2004, Scandinavian journal of immunology.
[15] A. Rothfuchs,et al. Macrophages, CD4+ or CD8+ Cells Are Each Sufficient for Protection against Chlamydia pneumoniae Infection through their Ability to Secrete IFN-γ1 , 2004, The Journal of Immunology.
[16] S. Ouellette,et al. Chlamydia pneumoniae and atherosclerosis , 2004, Cellular microbiology.
[17] T. Hackstadt,et al. Golgi-dependent transport of cholesterol to the Chlamydia trachomatis inclusion , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[18] M. D’Elios,et al. T helper type 1 lymphocytes drive inflammation in human atherosclerotic lesions , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[19] M. Rosenfeld,et al. Foam Cell Formation Inhibits Growth of Chlamydia pneumoniae but Does Not Attenuate Chlamydia pneumoniae–Induced Secretion of Proinflammatory Cytokines , 2002, Circulation.
[20] M. Rosenfeld,et al. Chlamydia pneumoniae infection and atherosclerosis: methodological considerations. , 2002, Circulation.
[21] S. Ouellette,et al. Chlamydia trachomatis Persistence in the Female Mouse Genital Tract: Inducible Nitric Oxide Synthase and Infection Outcome , 2001, Infection and Immunity.
[22] G. Hansson,et al. Chlamydia pneumoniae Infection Does Not Induce or Modify Atherosclerosis in Mice , 2001, Circulation.
[23] KatriinaAalto-Setälä,et al. Chlamydia pneumoniae Does Not Increase Atherosclerosis in the Aortic Root of Apolipoprotein E–Deficient Mice , 2001 .
[24] R. Zinkernagel,et al. Hypercholesterolemia Exacerbates Virus-Induced Immunopathologic Liver Disease Via Suppression of Antiviral Cytotoxic T Cell Responses1 , 2001, The Journal of Immunology.
[25] S. Swain,et al. Reciprocal regulation of polarized cytokine production by effector B and T cells , 2000, Nature Immunology.
[26] P. Roholl,et al. Chlamydia pneumoniae antigens, rather than viable bacteria, persist in atherosclerotic lesions , 2000, Journal of clinical pathology.
[27] S. Caspar-Bauguil,et al. Chlamydia pneumoniae induces interleukin-10 production that down-regulates major histocompatibility complex class I expression. , 2000, The Journal of infectious diseases.
[28] Stalenhoef,et al. Apolipoprotein E‐deficient mice have an impaired immune response to Klebsiella pneumoniae , 2000, European journal of clinical investigation.
[29] M. Rosenfeld,et al. Mouse models of C. pneumoniae infection and atherosclerosis. , 2000, The Journal of infectious diseases.
[30] G. Hansson,et al. The Role of Adaptive Immunity in Atherosclerosis , 2000, Annals of the New York Academy of Sciences.
[31] V. Levitsky,et al. Regulation and Role of IFN-γ in the Innate Resistance to Infection with Chlamydia pneumoniae1 , 2000, The Journal of Immunology.
[32] D. Schmechel,et al. Altered immune responses in apolipoprotein E-deficient mice. , 2000, Journal of lipid research.
[33] G. Byrne,et al. Chlamydia pneumoniae and atherosclerosis: links to the disease process. , 1999, American heart journal.
[34] M. Rosenfeld,et al. Chlamydia pneumoniae infection accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice. , 1999, The Journal of infectious diseases.
[35] H. Wigzell,et al. Role of innate and adaptive immunity in the outcome of primary infection with Chlamydia pneumoniae, as analyzed in genetically modified mice. , 1999, Journal of immunology.
[36] A. Daugherty,et al. Apolipoprotein E-deficient mice have impaired innate immune responses to Listeria monocytogenes in vivo. , 1998, Journal of lipid research.
[37] T. Quinn,et al. Identification of Chlamydia pneumoniae by DNA amplification of the 16S rRNA gene , 1992, Journal of clinical microbiology.
[38] N. Therville,et al. Interleukin-6 deficiency fails to prevent chronic rejection after aortic allografts in apolipoprotein E-deficient mice. , 2009, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[39] M. Ravaoarinoro,et al. Chlamydia trachomatis persistence: an update. , 2006, Microbiological research.
[40] A. Nègre-Salvayre,et al. Chlamydia pneumoniae alters mildly oxidized low-density lipoprotein-induced cell death in human endothelial cells, leading to necrosis rather than apoptosis. , 2006, The Journal of infectious diseases.
[41] L. Mannonen,et al. IFN-gamma induced persistent Chlamydia pneumoniae infection in HL and Mono Mac 6 cells: characterization by real-time quantitative PCR and culture. , 2004, Microbial pathogenesis.
[42] C. Merril,et al. Chlamydia pneumoniae Secretion of a Protease-Like Activity Factor for Degrading Host Cell Transcription Factors Required for Major Histocompatibility Complex Antigen Expression , 2002 .